Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$28.21 - $37.78 $1,946 - $2,606
69 Added 0.79%
8,758 $266,000
Q4 2023

Feb 14, 2024

BUY
$32.99 - $43.25 $46,153 - $60,506
1,399 Added 19.19%
8,689 $310,000
Q3 2023

Nov 14, 2023

SELL
$41.12 - $57.73 $5,098 - $7,158
-124 Reduced 1.67%
7,290 $319,000
Q2 2023

Aug 14, 2023

BUY
$40.44 - $49.6 $566 - $694
14 Added 0.19%
7,414 $365,000
Q1 2023

May 15, 2023

BUY
$35.87 - $47.22 $8,967 - $11,805
250 Added 3.5%
7,400 $306,000
Q4 2022

Feb 13, 2023

BUY
$33.48 - $47.45 $18,447 - $26,144
551 Added 8.35%
7,150 $317,000
Q3 2022

Nov 09, 2022

BUY
$38.25 - $52.62 $252,411 - $347,239
6,599 New
6,599 $258,000

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.62B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Snowden Capital Advisors LLC Portfolio

Follow Snowden Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.